Oruka Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Oruka Therapeutics, Inc. (ORKA) reported Capital Expenditures Incurred but Not yet Paid of $2.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-10-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2022-10-28
- Oruka Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-09-30 was -$6.00K.
- Oruka Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-06-30 was $5.00K.
- Oruka Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $3.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|---|
| 2021-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$1.00K derived: sum of 2 quarters · filed 2022-10-28 | $2.00K 10-Q · filed 2022-10-28 |
| 2021-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $8.00K 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-02 | ||
| 2018-06-30 | $1.00K 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |